Database
User
| Toxicity | Dose | Time | Species | Model | Method | Action | Positive criterion | Reference |
|---|---|---|---|---|---|---|---|---|
| MEMBRANE POTENTIAL | 13.53±1.90 | human | qHTS-HepG2 | MMP assay | decrease | IC50 | 163 | |
| MEMBRANE POTENTIAL | human | HepG2 | MMP assay | Negative | IC50 | 163 | ||
| MEMBRANE POTENTIAL | rat | hepatocytes | MMP assay | Negative | IC50 | 163 | ||
| (9Z)-N-(4-Hydroxy-3-methoxybenzyl)-9-octadecenamide # | (9Z)-N-[(4-hydroxy-3-methoxyphenyl)methyl]octadec-9-enamide | (N-Vanillyl)-9-oleamide |
| (Z)-N-[(4-hydroxy-3-methoxy-phenyl)methyl]octadec-9-enamide | (Z)-N-[(4-hydroxy-3-methoxyphenyl)methyl]octadec-9-enamide | (Z)-Octadec-9-enoic acid, amide, N-(4-hydroxy-3-methoxyphenyl)-; |
| 1967AH | 3-13-00-02192 (Beilstein Handbook Reference) | 4P7KIU7003 |
| 58493-49-5 | 9-Octadecenamide, N-((4-hydroxy-3-methoxyphenyl)methyl)-, (Z)- | 9-Octadecenamide, N-[(4-hydroxy-3-methoxyphenyl)methyl]-, (Z)- |
| AKOS024458705 | B6512 | BDBM20460 |
| BN0398 | CAS-58493-49-5 | CCG-221972 |
| CHEMBL76903 | D05249 | DSSTox_CID_25669 |
| DSSTox_GSID_45669 | DSSTox_RID_81044 | DTXSID1045669 |
| GTPL2488 | HMS3262E17 | HMS3411J12 |
| HMS3649J03 | HMS3675J12 | LP00668 |
| MFCD00673962 | N-((4-Hydroxy-3-methoxyphenyl)methyl)-9-octadecenamide (Z)- | N-Vanillyloleamide |
| N-Vanillyloleoylamide | N-Vannilyloleoylamide | NCGC00024885-01 |
| NCGC00024885-02 | NCGC00024885-03 | NCGC00261353-01 |
| NE 19550 | NE-19550 | OLVANIL |
| OPZKBPQVWDSATI-KHPPLWFESA-N | Olvanil (USAN) | Olvanil [USAN:INN] |
| Olvanil, powder | Olvanilo | Olvanilo [Spanish] |
| Olvanilum | Olvanilum [Latin] | Q27088176 |
| SCHEMBL94262 | SR-01000597478 | SR-01000597478-1 |
| SR-01000597478-3 | TCMDC-124289 | Tocris-0934 |
| Tox21_110935 | Tox21_110935_1 | Tox21_500668 |
| UNII-4P7KIU7003 | Vanillyloleamide | ZINC8036019 |